Cancer biology is a rapidly evolving field, with pathology and biomarker research at the forefront of innovations in diagnosis, classification, and ...

AI in Pathology Market OverviewThe global AI in pathology market is anticipated to witness robust expansion, growing at an ...

Advances in artificial intelligence and multimodal data integration are poised to revolutionise cancer diagnostics – but significant challenges remain before these technologies can be routinely ...

Explore how biochemistry, microbiology, and pathology collaborate in cancer care for early detection, personalized treatment, and survival monitoring.

Kivo reports AI accelerates cancer research by analyzing large datasets, improving clinical trial matching, and expediting biomarker discovery.

This article explores how tissue-based companion diagnostics leveraging immunohistochemistry approaches will help to select patients for targeted cancer treatments.

Valar Labs is a precision oncology company using artificial intelligence to reduce the uncertainty in cancer treatment. By analyzing standard pathology slides, Valar's AI biomarkers predict response ...

Craig Griffeth, 74, has always worried about cancer. “My aunts and uncles, almost all of them on both sides, died of cancer,” he said. “So, I figured that one day I’m going to get cancer, and I’ll ...

Early detection and accurate typing of cancer are critical for improving patient survival rates. While traditional pathology remains the gold standard, it often requires complex sample processing and ...

Immunotherapy given before or after surgery is increasingly used across several cancer areas. In an article published in the Journal of Internal ...